What we do
We are revolutionising paediatric healthcare and research by funding cutting-edge infrastructure, research and treatments for rare conditions, and clinical trials to deliver the best possible care for patients and their families.
We turn research into new treatments for children
- As an alliance between clinical and research organisations, we enable clinicians to drive the research agenda (bedside to benchtop) and researchers to support rapid translation of their work in our hospitals (benchtop to bedside).
- We underpin the research done by our partners through enabling platforms like bioinformatics, health economics, implementation and psychosocial research.
- We also provide seed funding for blue-sky research in innovation projects.
We possess the necessary scale to actively drive change
- Greater collaboration means we can achieve the critical mass in NSW that we need to do truly transformative research. Together, our member organisations can achieve more that any one organisation can on its own.
- When researching treatments for rare diseases, there are often only a handful of patients in the world. Sydney Children’s Hospital Network sees more than 35% of the sickest children in Australia. In turn, these children get access to brand new treatments and clinical trials.
- Our scale also provides opportunities for collaboration and cost saving, for example through shared research platforms.
We achieve strength in collaboration
- The ‘omics’ revolution is showing us that diseases we once thought of as separate and unrelated may in fact share common roots, shared pathways or similar mechanisms.
- This realisation has created a new frontier of medical research, with unprecedented opportunities for improving children’s health.
- But collaboration is necessary to realise the benefits for children.
- Collaboration is the cornerstone of everything we do at Luminesce Alliance.
- Our members cover a wide range of paediatric health issues, from cancer and rare diseases to orthopaedic surgery and mental health.
- They also share approaches to healthcare including significant expertise in ‘omics’, use of new technologies such as 3D printing for surgery, and, increasingly, a focus on population health.
Read more about our research.